Table 3 Odds ratios for white coat hypertension (WCHT) and hypertension diagnosed by ambulatory blood pressure monitoring (ABPM hypertension) compared to normal blood pressure profile, comparing detectable or median levels of urinary phthalate metabolites

MCiNP ≥0.9 μg/L

0.40 (0.15–1.07)

0.41 (0.15–1.14)

0.48 (0.14–1.65)

0.63 (0.20–1.95)

0.60 (0.18–2.05)

0.45 (0.09–2.30)

MCPP ≥0.5 μg/L

0.24 (0.09–0.66)

0.27 (0.09–0.76)

0.25 (0.08–0.87)

0.28 (0.06–1.46)

0.24 (0.07–0.80)

0.28 (0.08–0.97)

0.16 (0.03–0.91)

0.06 (0.01–0.74)

MEHHP ≥50 μg/L

1.9 (0.7–5.2)

2.2 (0.8–6.1)

3.5 (1.0–12.3)

3.5 (0.5–23.9)

1.4 (0.5–4.3)

1.7 (0.5–5.8)

3.2 (0.6–16.6)

2.7 (0.3–24.3)

Primary/secondary DEHP ≥6.9 μg/L

0.58 (0.22–1.54)

0.70 (0.25–198)

0.92 (0.27–3.09)

0.51 (0.16–1.59)

0.72 (0.21–2.52)

0.95 (0.20–4.53)

MBzP ≥DL

8.0 (1.6–39.7)

8.5 (1.6–44.4)

6.0 (1.0–36.8)

33.5 (2.1–539.6)

11.6 (2.1–63.3)

14.1 (2.3–86.8)

15.2 (1.9–122.7)

50.5 (3.1–846.7)

ΣDBP met≥40 μg/L

0.16 (0.05–0.45)

0.16 (0.05–0.49)

0.12 (0.03–0.46)

0.06 (0.01–0.38)

0.40 (0.12–1.30)

0.49 (0.14–1.75)

0.60 (0.11–3.22)

0.98 (0.09–10.12)

MEP ≥20 μg/L

0.51 (0.19–1.36)

0.64 (0.23–1.84)

0.71 (0.22–2.28)

1.35 (0.43–4.28)

1.85 (0.52–6.63)

2.80 (0.57–13.92)

MMP ≥2.6 μg/L

0.35 (0.13–0.95)

0.27 (0.09–0.79)

0.20 (0.05–0.71)

0.17 (0.03–0.86)

0.69 (0.22–2.14)

0.49 (0.14–1.71)

0.35 (0.07–1.79)

0.15 (0.02–1.19)